FDA Rejects Petitions Related to Abortion Pill Mifepristone

FDA Rejects Petitions Related to Abortion Pill Mifepristone
A woman looks at an abortion pill—RU-486, or mifepristone—displayed on a smartphone in Arlington, Va., on May 8, 2020. Olivier Douliery/AFP via Getty Images
Updated:
0:00

The U.S. Food and Drug Administration (FDA) recently denied two petitions—one from pro-life group Students for Life, and one from the American College of Obstetricians and Gynecologists (ACOG)—regarding an abortion pill, marking the latest move in efforts to determine regulation over chemical abortion.

Chemical abortion, also referred to by other terms such as “abortion by medication,” is the most popular method of abortion in the United States, comprising more than half of total U.S. abortions.

Related Topics